Literature DB >> 7484579

Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma.

P Soyer1, D A Bluemke, R Reichle, P S Calhoun, D F Bliss, A Scherrer, E K Fishman.   

Abstract

Cholangiocarcinoma is the second most common primary hepatic malignant tumor after hepatocellular carcinoma, accounting for 5-30% of all primary hepatic malignant tumors [1]. Intrahepatic cholangiocarcinomas can be classified as peripheral cholangiocarcinoma, which originates from an interlobular biliary duct, or as hilar cholangiocarcinoma, which originates from a main hepatic duct or from the bifurcation of the common hepatic duct. Intrahepatic cholangiocarcinomas account for only about half of cholangiocarcinomas, and this pictorial essay focuses only on the peripheral form of the disease. Clinically, therapeutically, and radiologically, these two types of cholangiocarcinomas differ. Features suggestive of the diagnosis of peripheral cholangiocarcinoma can be shown by sonography, CT, and MR imaging. Cholangiography and angiography have a limited role in evaluating this neoplasm that manifests as a focal mass. This essay reviews the appearances of peripheral cholangiocarcinoma and discusses the various imaging techniques that can be used to evaluate this unusual tumor that is often resectable and potentially curable.

Entities:  

Mesh:

Year:  1995        PMID: 7484579     DOI: 10.2214/ajr.165.6.7484579

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

Authors:  Eugene J Koay; Bruno C Odisio; Milind Javle; Jean-Nicolas Vauthey; Christopher H Crane
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

Review 2.  [Radiological diagnosis of primary hepatic malignancy].

Authors:  Benjamin Henninger; Johannes Petersen; Werner Jaschke
Journal:  Wien Med Wochenschr       Date:  2013-02-08

3.  Role of magnetic resonance cholangiopancreatography in the evaluation of biliary disease.

Authors:  Humoud Al-Dhuhli
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

Review 4.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Authors:  Young-Jin Kim; Mijin Yun; Woo Jung Lee; Kyung Sik Kim; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-07       Impact factor: 9.236

6.  Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.

Authors:  M D'Onofrio; F Vecchiato; V Cantisani; E Barbi; M Passamonti; P Ricci; R Malagò; N Faccioli; G Zamboni; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

7.  Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

Authors:  Aliya F Gulamhusein; John E Eaton; James H Tabibian; Elizabeth J Atkinson; Brian D Juran; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864

8.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

9.  Magnetic Resonance Imaging of cholangiocarcinoma.

Authors:  Katrina A Vanderveen; Hero K Hussain
Journal:  Cancer Imaging       Date:  2004-04-06       Impact factor: 3.909

10.  Liver metastases: imaging considerations for protocol development with multislice CT (MSCT).

Authors:  Paul M Silverman
Journal:  Cancer Imaging       Date:  2006-11-08       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.